Nomura's Takeaways From Meeting With Gilead Sciences' Management
January 16, 2015 at 10:17 AM EST
Ian Somaiya of Nomura on Friday reiterated a Buy rating on shares of Gilead Sciences, Inc. (NASDAQ: GILD) with a $146 price target ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.